ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPERUsefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences
Ostanek L, Brzosko M, Fischer K. ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPERUsefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences. Reumatologia/Rheumatology. 2005;43(6):354-357.
APA
Ostanek, L., Brzosko, M., & Fischer, K. (2005). ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPERUsefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences. Reumatologia/Rheumatology, 43(6), 354-357.
Chicago
Ostanek, Lidia, Marek Brzosko, and Katarzyna Fischer. 2005. "ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPERUsefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences". Reumatologia/Rheumatology 43 (6): 354-357.
Harvard
Ostanek, L., Brzosko, M., and Fischer, K. (2005). ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPERUsefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences. Reumatologia/Rheumatology, 43(6), pp.354-357.
MLA
Ostanek, Lidia et al. "ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPERUsefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences." Reumatologia/Rheumatology, vol. 43, no. 6, 2005, pp. 354-357.
Vancouver
Ostanek L, Brzosko M, Fischer K. ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPERUsefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences. Reumatologia/Rheumatology. 2005;43(6):354-357.
The presence of anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) is considered among diagnostic criteria of antiphospholipid syndrome (APS). Studies during the last decade revealed that also other antibodies, mainly antiprothrombin antibodies and anti-b22-glycoprotein I (ab2GPI), belong to antiphospholipid antibodies, which play significant role in the developing of APS. The review of papers on incidence and clinical significance of the antibodies, as well as own experiences are presented.